We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current MLTX market cap is 2.88B. The company's latest EPS is USD -0.6901 and P/E is -65.31.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -12.93M | -13.19M | -12.98M | -15.03M | -19.82M |
| Net Income | -12.22M | -12.35M | -11.62M | -7.89M | -13.98M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -106k | -4.57M | -65.06M | -54.12M |
| Net Income | -91k | -4.54M | -64.51M | -44.08M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Assets | 66.8M | 506.62M | 500.22M | 526.54M | 564.12M |
| Total Liabilities | 7.69M | 7.51M | 10.58M | 13.05M | 11.73M |
| Total Equity | 59.11M | 499.11M | 489.64M | 513.49M | 552.39M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 116.63M | 115.84M | 76.84M | 526.54M |
| Total Liabilities | 4.15M | 7.9M | 8.08M | 13.05M |
| Total Equity | 5M | -7.06M | 68.77M | 513.49M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Operating | -9.02M | -21.18M | -30.43M | -42.78M | -14.95M |
| Investing | 19.65M | 32.33M | -142.05M | -25.19M | -28.8M |
| Financing | N/A | 451.29M | 451.29M | 479.7M | 50.98M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -317k | -611k | -55.89M | -42.78M |
| Investing | -115M | N/A | -32.34M | -25.19M |
| Financing | 116.65M | -58k | 119.69M | 479.7M |
| Market Cap | 2.88B |
| Price to Earnings Ratio | -65.31 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 6.38 |
| Price to Book Ratio | 5.61 |
| Dividend Yield | - |
| Shares Outstanding | 63.87M |
| Average Volume (1 week) | 554.62k |
| Average Volume (1 Month) | 455.93k |
| 52 Week Change | -22.62% |
| 52 Week High | 64.98 |
| 52 Week Low | 35.11 |
| Spread (Intraday) | 47.97 (72.68%) |
| Company Name | MoonLake Immunotherapeutics |
| Address |
p.o. box 309 grand cayman 1104 |
| Website | https://moonlaketx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
